← FDA DRUG APPROVALS

FDA NDA · NDA017042

FLUORINE F-18

Sponsor: GE HEALTHCARE

APPLICATION
NDA017042
TYPE
NDA
ORIGINAL APPROVAL
1972-02-24
LATEST ACTION
1972-02-24
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

FLUORINE F-18 · ReferenceDiscontinued
SODIUM FLUORIDE F-18 2mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INTRAVENOUS

Approval history

1972-02-24Type 1 - New Molecular Entity · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →